Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
APLP2 - CD14 cells from granulocyte colony stimulating factor mobilized peripheral blood: expression profile
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APLP2 - Rapamycin-resistant diffuse large B-cell lymphoma cell lines
APLP2 - Intravenous corticosteroid therapy effect on children with severe ulcerative colitis: peripheral blood
APLP2 - Multiple sclerosis: peripheral blood mononuclear cells
APLP2 - Type 2 diabetes and insulin resistance (HuGeneFL)
APLP2 - Saracatinib-sensitive versus -resistant, PIK3CA mutant colorectal cancer xenografts
APLP2 - Lymphoblastoid cell response to low-dose cadmium exposure in vitro
APLP2 - Congestive heart failure
APLP2 - Morbidly obese and non-obese individuals: adipose stem cells
APLP2 - Juvenile dermatomyositis muscle profile (MuscleChip)
APLP2 - Cisplatin-resistant non-small cell lung cancer cell line
APLP2 - ZNF750 silencing effect on differentiated keratinocytes
APLP2 - Juvenile dermatomyositis muscle profile (HuGeneFL)
APLP2 - Resveratrol (resVida) effect on obese men: vastus lateralis muscle biopsies
APLP2 - Rho-associated kinase deficiency effect on coronary artery smooth muscle cells in vitro
APLP2 - Progressive pulmonary sarcoidosis
APLP2 - Mutant p53 depletion effect on MDA-468.shp53 breast tumor cell line
APLP2 - Skeletal muscle response to insulin infusion (HuGeneFL)
APLP2 - Entamoeba histolytica infected sigmoid colon
APLP2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on